Related references
Note: Only part of the references are listed.Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD)
Stephen J. Seligman
VACCINE (2014)
Safety profile of the yellow fever vaccine Stamaril®: a 17-year review
Pascale Cottin et al.
EXPERT REVIEW OF VACCINES (2013)
How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria?
Roger E. Thomas et al.
VACCINE (2013)
Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: A systematic review
Ellen Rafferty et al.
VACCINE (2013)
Review of the risks and benefits of yellow fever vaccination including some new analyses
Thomas P. Monath
EXPERT REVIEW OF VACCINES (2012)
Viscerotropic disease: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
Mark D. Gershman et al.
VACCINE (2012)
The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever
Emily S. Jentes et al.
LANCET INFECTIOUS DISEASES (2011)
Short Report: Suspected Yellow Fever Vaccine-Associated Viscerotropic Adverse Events (1973 and 1978), United States
Thomas P. Monath
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Share Paper
